Featured Image

WASHINGTON (LifeSiteNews) — A new groundbreaking study found that ER visits following the use of abortion-inducing pills have increased over 500 percent since 2002. At the same time, the FDA is considering loosening restrictions on the drugs.

The study from the pro-life Charlotte Lozier Institute (CLI) published on November 9 found that emergency room visits following the ingestion of the abortion-inducing drugs mifepristone and misoprostol have skyrocketed over 500 percent between 2002 and 2015. Doctors now warn the Food and Drug Administration (FDA) of the drugs’ dangers ahead of a December 16 meeting where the agency will consider permanently loosening the safety regulations surrounding the infanticide pills.

The study, which analyzed Medicaid claims data, uncovered that chemical abortions pose a “22% greater risk of ER visit for any reason,” and a “53% greater risk of ER visit for an abortion-related reason,” when compared to the already potentially injurious surgical abortions.

More disturbing, “Over 60% of abortion-related ER visits following a chemical abortion in 2015 were miscoded as treatment for a miscarriage,” stated the study, suggesting the real damage done by the drugs is unclear, due to either intentional coverup or medical oversight.

CLI’s study found that the highly dangerous chemical abortions have massively increased in popularity, growing from 4.4% of total abortions to a whopping 34.1% during the study period. Even more recent 2020 figures show these drugs are responsible for over half the abortions in America.

According to Dr. James Studnicki, CLI vice president of data analytics, “The safety of chemical abortion is greatly exaggerated. In fact, the increasing dominance of chemical abortion and its disproportionate contribution to emergency room morbidity is a serious public health threat, and the real-world data suggests the threat is growing.”

“Women are far more likely to visit the emergency room following a chemical rather than surgical abortion. The rate of these emergency room visits is growing remarkably fast. It is therefore terrifying that the FDA is actively being pressured to eliminate longstanding public health safeguards on the abortion pill. This comprehensive data advocates for the FDA to strengthen, rather than weaken, medical oversight of chemical abortion.”

Despite the dangers, at the beginning of the so-called COVID-19 pandemic the Biden administration waived the FDA’s safety regulations for the abortion-inducing drugs, allowing the now-proven-to-be harmful pills to be prescribed and delivered to women without them ever having to see a doctor.

On December 16, the FDA plans to see if the Biden administration’s relaxation of the safety regulations should be upheld indefinitely, making the drugs’ availability through the mail without a doctor’s visit a permanent fixture of the abortion industry.

Prior to both the study and Biden’s decision, the safety of chemical abortion was already contested by many pro-life advocates and doctors, as mifepristone, one of the drugs used in the procedure, had already been linked to 24 deaths and 4,000 injuries in America alone.

“Pro-abortion activists have exploited the COVID-19 pandemic from the beginning, working to eliminate safety precautions in order to expand the proliferation of dangerous chemical abortion drugs,” Susan B. Anthony List president Marjorie Dannenfelser said in April. “This decision prioritizes abortion industry profits over the health and safety of women and puts the abortion extremism of the Biden-Harris administration on full display.”

“Sending deadly pills through the mail without any pre-screening or follow up care is convenient and cost effect for Corporate Abortion, but women will pay the price along with countless preborn infants,” added Students for Life Action President Kristan Hawkins.